A sedentary lifestyle is now recognized as a major risk factor not only for cardiovascular disease, but also for psychiatric disorders. In the context of mental health and recovery, physical activity is no longer considered a mere leisure activity, but a therapeutic intervention. A recent meta-analysis published in JAMA Psychiatry highlighted the dose-response relationship between the amount of physical activity and the incidence of major depression.

Brain plasticity and BDNF

The key mechanism lies in neuroplasticity. Moderate aerobic exercise, such as brisk walking, stimulates the production of an essential protein: brain-derived neurotrophic factor (BDNF).
BDNF acts as a “fertilizer” for neurons, promoting neurogenesis (the creation of new cells) and synaptogenesis (the creation of new connections), particularly in the hippocampus. This region of the brain, responsible for memory and emotional regulation, is often atrophied in patients suffering from chronic depression or substance use disorders.

Clinical results: the threshold for effectiveness

Analysis of data from more than 190,000 participants shows that it is not necessary to reach exhaustion to achieve results. An activity level equivalent to 2.5 hours of brisk walking per week (about 20 minutes per day) is associated with a 25% reduction in the risk of depression. Beyond this threshold, the benefits continue to increase, but it is the transition from “nothing” to “a little” that offers the most dramatic therapeutic gain.

Walking acts as an endogenous antidepressant by modulating brain chemistry and reducing systemic inflammation. For public health programs, it represents a first-rate preventive strategy that is accessible and has no undesirable side effects.